Tamil Nadu Urological Research Centre Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 5.88 M
- Company Age 32 Year, 21 Days
- Last Filing with ROC 29 Sep 2018
- Revenue Growth 1.90%
- Profit Growth -128.90%
- Ebitda -45.22%
- Net Worth -1.32%
- Total Assets -2.47%
About Tamil Nadu Urological Research Centre
Tamil Nadu Urological Research Centre Limited (TNURCL) is a Public Limited Indian Non-Government Company incorporated in India on 18 January 1993 and has a history of 32 years. Its registered office is in Aminjikarai., Tamil Nadu, India.
The Corporate was formerly known as Tamil Nadu Urological Research Centre Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 29 September 2018. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.88 M, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Aminjikarai., Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85110TN1993PLC024202
-
Company No.
024202
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
18 Jan 1993
-
Date of AGM
22 Sep 2018
-
Date of Balance Sheet
29 Sep 2018
-
Listing Status
Unlisted
-
ROC Code
Roc-Chennai
Industry
Who are the key members and board of directors at Tamil Nadu Urological Research Centre?
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Tamil Nadu Urological Research Centre.
Tamil Nadu Urological Research Centre Limited, for the financial year ended 2018, experienced modest growth in revenue, with a 1.9% increase. The company also saw a substantial fall in profitability, with a 128.9% decrease in profit. The company's net worth dipped by a decrease of 1.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tamil Nadu Urological Research Centre?
In 2018, Tamil Nadu Urological Research Centre had a promoter holding of 15.37% and a public holding of 84.63%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tamil Nadu Urological Research Centre?
Tamil Nadu Urological Research Centre has a workforce of 7 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tamil Nadu Urological Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tamil Nadu Urological Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
